Page 14 - முதலீட்டாளர் உறவுகள் பெருநிறுவன வளர்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Smith Micro to Present at the 16th Annual Needham Virtual Technology & Media Conference on May 17, 2021 – Consumer Electronics Net

Smith Micro to Present at the 16th Annual Needham Virtual Technology & Media Conference on May 17, 2021 – Consumer Electronics Net
consumerelectronicsnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from consumerelectronicsnet.com Daily Mail and Mail on Sunday newspapers.

Timothy huffmyerWilliamw smith jrCharles messmanNeedham companySmith micro software incInvestor relations corporate developmentVirtual technology media conferenceSmith micro softwareAnnual virtual technologyMedia conferenceSmith microInvestor relationsCorporate developmentEastern timeநீட்ஹாம் நிறுவனம்ஸ்மித் மைக்ரோ மென்பொருள் இன்க்

Diamond Offshore Names CEO

Diamond Offshore Names CEO Share this article Share this article HOUSTON, May 10, 2021 /PRNewswire/ Diamond Offshore Drilling, Inc. ( Diamond or the Company ) announced today that Bernie G. Wolford Jr. has been named the Company s President and Chief Executive Officer and will also serve on the Board of Directors. Mr. Wolford succeeds Marc Edwards, who retired from the Company as Chairman, President and Chief Executive Officer on April 23, 2021 when the Company and its debtor affiliates emerged from their chapter 11 financial restructuring. Mr. Wolford brings 40 years of industry and related experience to his leadership role at Diamond. He served as the Chief Executive Officer of Pacific Drilling S.A., from November 2018 to April 2021. From 2010 to 2018, Mr. Wolford served in senior operational roles at Noble Corporation, including five years as the company s Senior Vice President – Operations. He began his career with Transworld Drilling Company in 1981 and has worked i

United statesNealp goldmanMarc edwardsBernieg wolford jrSamir aliNoble corporationTransworld drilling companyInvestor relations corporate developmentSecurities exchangeDiamond offshore drilling incDiamond offshore drillingChief executive officerSenior vice presidentSecurities actSecurities exchange actRisk factors

Multisite Study Demonstrates Utility of Asuragen Kit for Identifying Variants Linked to Spinal Muscular Atrophy

Multisite Study Demonstrates Utility of Asuragen Kit for Identifying Variants Linked to Spinal Muscular Atrophy
mesabitribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mesabitribune.com Daily Mail and Mail on Sunday newspapers.

University of pennsylvaniaUnited statesJohnn milliganet alDavid clairGaryj lathamM van deerlinHenny lemminkPrnewswire bio techne corporationUniversity of pennsylvania perelman school medicineGenephile bioscience laboratoryClinical laboratory geneticistUniversity medical center groningenAsuragen incTurku university hospitalBio techne corporationInvestor relations corporate development

Bio-Techne Releases Third Quarter Fiscal 2021 Results

Share this article Share this article MINNEAPOLIS, May 6, 2021 /PRNewswire/ Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the third quarter ended March 31, 2021. Third Quarter FY2021 Snapshot Third quarter organic revenue increased by 22% (25% reported) to $243.6 million and 17% (19% reported) in the first nine months of fiscal 2021 to $672.0 million. GAAP EPS was $1.12 versus $0.92 one year ago. Delivered adjusted earnings per share (EPS) of $1.79 versus $1.39 one year ago. Adjusted Operating Margin increased to 40.1% in the third quarter of fiscal 2021 compared to 36.4% in the third quarter of fiscal 2020. Excellent commercial execution in both operating segments with Protein Sciences achieving record organic growth of 24% and Diagnostics and Genomics delivering 17% organic growth.

United statesChuck kummethDavid clairCompany diagnosticsCompany protein sciencesAsuragen incBio techne corporationExchange commissionProtein sciencesProtein sciences segmentInvestor relations corporate developmentOperating marginFinancial measuresGene therapyQuarter fiscalLooking statements

Bio-Techne Declares Dividend

Share this article Share this article MINNEAPOLIS, May 6, 2021 /PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended March 31, 2021. The quarterly dividend will be payable May 28, 2021 to all common shareholders of record on May 17, 2021. Future cash dividends will be considered by the Board of Directors on a quarterly basis. Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $739 million in net sales in fiscal 2020 and has over 2,300 employees wo

David clairInvestor relations corporate developmentBio techne corporationTechne corporationSenior directorInvestor relationsடேவிட் கிளேர்முதலீட்டாளர் உறவுகள் பெருநிறுவன வளர்ச்சிஉயிர் தொழில்நுட்பம் நிறுவனம்தொழில்நுட்பம் நிறுவனம்மூத்தவர் இயக்குனர்முதலீட்டாளர் உறவுகள்